These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14500593)

  • 1. Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase.
    Ahluwalia R; Freimuth R; McLeod HL; Marsh S
    Clin Chem; 2003 Oct; 49(10):1661-4. PubMed ID: 14500593
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening of dihydropyrimidine dehydrogenase genetic variants by direct sequencing in different ethnic groups.
    Shin JG; Cheong HS; Kim JY; Kim LH; Han CS; Kim JO; Kim HD; Kim YH; Chung MW; Han SY; Shin HD
    J Korean Med Sci; 2013 Aug; 28(8):1129-33. PubMed ID: 23960437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited association of the 2988g > a single nucleotide polymorphism with CYP2D641 in black subjects.
    Gaedigk A; Ndjountché L; Leeder JS; Bradford LD
    Clin Pharmacol Ther; 2005 Mar; 77(3):228-30; author reply 230-1. PubMed ID: 15735618
    [No Abstract]   [Full Text] [Related]  

  • 4. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.
    Lu Z; Zhang R; Diasio RB
    Clin Pharmacol Ther; 1995 Nov; 58(5):512-22. PubMed ID: 7586945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of a common dihydropyrimidine dehydrogenase mutation associated with 5-fluorouracil toxicity and congenital thymine uraciluria using fluorogenic hybridization probes.
    Nauck M; Gierens H; März W; Wieland H
    Clin Biochem; 2001 Mar; 34(2):103-5. PubMed ID: 11311218
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic variation in dihydropyrimidine dehydrogenase (DPYD) gene in a healthy adult Indian population.
    Iyer SN; Singhal RS; Hegde MR; Ankala A
    Ann Hum Biol; 2015 Jan; 42(1):97-100. PubMed ID: 25117664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism.
    Gross E; Seck K; Neubauer S; Mayr J; Hellebrand H; Ratanaphan A; Lutz V; Stockinger H; Kiechle M
    Int J Oncol; 2003 Feb; 22(2):325-32. PubMed ID: 12527930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C306A single nucleotide polymorphism in the human CEBPD gene that maps at 8p11.1-p11.2.
    Angeloni D; Lee JD; Johnson BE; Teh BT; Dean M; Lerman MI; Sterneck E
    Mol Cell Probes; 2001 Dec; 15(6):395-7. PubMed ID: 11851384
    [No Abstract]   [Full Text] [Related]  

  • 9. BiDil raises questions about race as a marker.
    Branca MA
    Nat Rev Drug Discov; 2005 Aug; 4(8):615-6. PubMed ID: 16106581
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity.
    Amstutz U; Froehlich TK; Largiadèr CR
    Pharmacogenomics; 2011 Sep; 12(9):1321-36. PubMed ID: 21919607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.
    Park CS; Kang JH; Chung WG; Yi HG; Pie JE; Park DK; Hines RN; McCarver DG; Cha YN
    Pharmacogenetics; 2002 Jan; 12(1):77-80. PubMed ID: 11773868
    [No Abstract]   [Full Text] [Related]  

  • 12. Genotype-phenotype correlations in 5-fluorouracil metabolism: a candidate DPYD haplotype to improve toxicity prediction.
    Gentile G; Botticelli A; Lionetto L; Mazzuca F; Simmaco M; Marchetti P; Borro M
    Pharmacogenomics J; 2016 Aug; 16(4):320-5. PubMed ID: 26216193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance.
    Morel A; Boisdron-Celle M; Fey L; Soulie P; Craipeau MC; Traore S; Gamelin E
    Mol Cancer Ther; 2006 Nov; 5(11):2895-904. PubMed ID: 17121937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of dihydropyrimidine dehydrogenase gene and clinical outcomes of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Zhang XP; Bai ZB; Chen BA; Feng JF; Yan F; Jiang Z; Zhong YJ; Wu JZ; Chen L; Lu ZH; Tong N; Zhang ZD; Xu PP; Peng MX; Zhang WJ; Wang S
    Chin Med J (Engl); 2012 Mar; 125(5):741-6. PubMed ID: 22490566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment.
    Amstutz U; Farese S; Aebi S; Largiadèr CR
    Pharmacogenomics; 2009 Jun; 10(6):931-44. PubMed ID: 19530960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil?
    Allegra CJ
    Clin Cancer Res; 1999 Aug; 5(8):1947-9. PubMed ID: 10473070
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals.
    Seck K; Riemer S; Kates R; Ullrich T; Lutz V; Harbeck N; Schmitt M; Kiechle M; Diasio R; Gross E
    Clin Cancer Res; 2005 Aug; 11(16):5886-92. PubMed ID: 16115930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tagging SNP rs1495741 and 2-SNPs (rs1041983 and rs1801280) yield a high prediction of the NAT2 genotype in HapMap samples.
    He YJ; Shapero MH; McLeod HL
    Pharmacogenet Genomics; 2012 Apr; 22(4):322-4. PubMed ID: 22414877
    [No Abstract]   [Full Text] [Related]  

  • 19. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
    Innocenti F; Ratain MJ
    Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity.
    van Kuilenburg AB; Haasjes J; Van Lenthe H; Zoetekouw L; Waterham HR; Vreken P; van Gennip AH
    Adv Exp Med Biol; 2000; 486():251-5. PubMed ID: 11783494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.